BioLine RX Ltd.


Wall Street’s Week Ahead: Wal-Mart Stores, Inc. (WMT), ReneSola Ltd. (ADR) (SOL), JD.COM Inc (ADR) (JD), Bioline RX Ltd (BLRX)

Earnings season rolls on this week with several companies releasing earnings reports. Here’s what to watch for from Wal-Mart Stores, Inc.

Company Update (NASDAQ:BLRX): Bioline RX Ltd Announces Positive Clinical Results from First Part of Phase 2 Trial in r/r AML

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today positive results from the dose …

Stock Update (NASDAQ:BLRX): Bioline RX Ltd Announces Regulatory Submission for Phase 2 Trial of BL-8040 as Novel Treatment for Hypoplastic Myelodysplastic Syndrome and Aplastic Anemia

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has filed the …

Stock Update (NASDAQ:BLRX): Bioline RX Ltd’s Novel Treatment for Non-Surgical Removal of Skin Lesions Submitted for CE Mark Registration

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its partner, Omega Pharma, …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Reports Second Quarter 2015 Financial Results

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for the …

Bioline RX Ltd (BLRX) Bullish Stance Reiterated at Roth Capital Amid BL-8040 Phase IIb Initiation

Roth Capital’s healthcare analyst Joseph Pantginis weighed in with a few insights on Bioline RX Ltd (NASDAQ:BLRX), after the company announced the initiation of the Phase …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Announces Initiation of Phase 2b Trial for Novel AML Consolidation Treatment

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today the initiation of a Phase …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Announces Top-Line Results from Bellerophon’s PRESERVATION I Clinical Trial

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its partner, Bellerophon, reported …

Roth Capital Reiterates Buy on Bioline RX Ltd; Here’s Why

In a research report issued June 22, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Bioline RX Ltd (NASDAQ:BLRX) with a price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts